| Disease associated variation - GWASdb |
| Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
|---|
| 3 | 33336370 | rs7628482 | C | T | rs7628482 | 0.0005823 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_drug |
| 3 | 33336370 | rs7628482 | C | T | rs7628482 | 5.82E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_drug |
| 3 | 33336370 | rs7628482 | C | T | rs7628482 | 0.0005823 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | C | intron | GWASdb_trait |
| 3 | 33336370 | rs7628482 | C | T | rs7628482 | 5.82E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | C | intron | GWASdb_trait |
| 3 | 33388184 | rs6769005 | T | A | rs6769005 | 8.13E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | A | intron | GWASdb_trait |
| 3 | 33413263 | rs4678929 | T | G | rs4678929 | 1.73E-05 | | | Behcet's disease | HPOID:0011955 | DOID:13241 | T | intron | GWASdb_trait |
| 3 | 33419422 | rs2291897 | C | T | rs2291897 | 1.47E-05 | | | Behcet's disease | HPOID:0011955 | DOID:13241 | G | intron | GWASdb_trait |
| 3 | 33419422 | rs2291897 | C | T | rs2291897 | 1.82E-05 | | | Behcet's disease | HPOID:0011955 | DOID:13241 | G | intron | GWASdb_trait |
| 3 | 33421178 | rs4045539 | A | C | rs4045539 | 1.56E-05 | | | Behcet's disease | HPOID:0011955 | DOID:13241 | T | intron | GWASdb_trait |